BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30921344)

  • 1. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    Thilakarathne DS; Coppo MJC; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Vaz PK; Devlin JM
    PLoS One; 2019; 14(3):e0213866. PubMed ID: 30921344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latency characteristics in specific pathogen-free chickens 21 and 35 days after intra-tracheal inoculation with vaccine or field strains of infectious laryngotracheitis virus.
    Thilakarathne DS; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Coppo MJC; Devlin JM
    Avian Pathol; 2020 Aug; 49(4):369-379. PubMed ID: 32352307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG; Kim SJ
    Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
    Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.
    Coppo MJ; Devlin JM; Noormohammadi AH
    Avian Pathol; 2012; 41(1):99-106. PubMed ID: 22845327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
    Legione AR; Coppo MJ; Lee SW; Noormohammadi AH; Hartley CA; Browning GF; Gilkerson JR; O'Rourke D; Devlin JM
    Vaccine; 2012 Nov; 30(50):7193-8. PubMed ID: 23084851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of A20 infectious laryngotracheitis vaccine take in meat chickens using swab and dust samples following mass vaccination in drinking water.
    Assen AM; Stillman M; Alfirevich S; Gerber PF; Groves PJ; Walkden-Brown SW
    Vet Microbiol; 2020 Dec; 251():108903. PubMed ID: 33176212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and application of a combined molecular and tissue culture-based approach to detect latent infectious laryngotracheitis virus (ILTV) in chickens.
    Thilakarathne DS; Hartley CA; Diaz-Méndez A; Coppo MJC; Devlin JM
    J Virol Methods; 2020 Mar; 277():113797. PubMed ID: 31821819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickens.
    Korsa MG; Devlin JM; Hartley CA; Browning GF; Coppo MJC; Quinteros JA; Loncoman CA; Onasanya AE; Thilakarathne D; Diaz-Méndez A
    PLoS One; 2018; 13(12):e0207611. PubMed ID: 30521554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.
    Devlin JM; Hartley CA; Gilkerson JR; Coppo MJ; Vaz P; Noormohammadi AH; Wells B; Rubite A; Dhand NK; Browning GF
    Vaccine; 2011 Aug; 29(34):5699-704. PubMed ID: 21689710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.
    Rodríguez-Avila A; Oldoni I; Riblet S; Garcia M
    Avian Pathol; 2008 Jun; 37(3):287-92. PubMed ID: 18568655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication and transmission of live attenuated infectious laryngotracheitis virus (ILTV) vaccines.
    Rodríguez-Avila A; Oldoni I; Riblet S; García M
    Avian Dis; 2007 Dec; 51(4):905-11. PubMed ID: 18251401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an enzyme-linked immunosorbent assay to detect chicken serum antibody to glycoprotein G of infectious laryngotracheitis virus.
    Shil NK; Markham PF; Noormohammadi AH; O'Rourke D; Devlin JM
    Avian Dis; 2012 Sep; 56(3):509-15. PubMed ID: 23050467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the transcriptional status of host cytokines and viral genes in the trachea of vaccinated and non-vaccinated chickens after challenge with the infectious laryngotracheitis virus.
    Vagnozzi A; Riblet S; Zavala G; Ecco R; Afonso CL; García M
    Avian Pathol; 2016; 45(1):106-13. PubMed ID: 26926298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
    Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers.
    Palomino-Tapia VA; Zavala G; Cheng S; García M
    Avian Pathol; 2019 Jun; 48(3):209-220. PubMed ID: 30640536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Responses in the Eye-Associated Lymphoid Tissues of Chickens after Ocular Inoculation with Vaccine and Virulent Strains of the Respiratory Infectious Laryngotracheitis Virus (ILTV).
    Beltrán G; Hurley DJ; Gogal RM; Sharif S; Read LR; Williams SM; Jerry CF; Maekawa DA; García M
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31295877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence and spreading of field and vaccine strains of infectious laryngotracheitis virus (ILTV) in vaccinated and unvaccinated geographic regions, in Brazil.
    Chacón JL; Núñez LF; Vejarano MP; Parra SH; Astolfi-Ferreira CS; Ferreira AJ
    Trop Anim Health Prod; 2015 Aug; 47(6):1101-8. PubMed ID: 25904510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.